Starling Medical

Starling Medical is developing an at-home urine diagnostic patient-monitoring platform called StarStream. The device attaches to a toilet and uses artificial intelligence and spectroscopic sensors to analyze urine samples directly, eliminating the need for traditional collection containers or dipsticks. StarStream aims to prevent hospitalizations from chronic conditions such as urinary tract infections, diabetes, and kidney disease. The company plans to expand its capabilities to detect dozens of additional health disorders through urine testing, including preeclampsia in pregnant women.

Starling Medical's technology connects patients with their doctors if any health issues are detected after toilet use. The company has conducted a clinical trial to validate its prediction models. Starling Medical was preparing to deploy StarStream with its first enterprise customer, a large private practice in Texas with approximately 200,000 urology patients. The company claims StarStream is the world's first FDA-registered service of its kind, offering analysis and connection to care.

StarStream is actually Starling Medical's second product iteration. The company's initial focus was on developing a catheter device for patients with neurological bladder dysfunction. This device would allow patients to urinate at the press of a button and monitor their bladder for urinary tract infections. However, the company later decided to adapt its technology for broader use by incorporating sensors into a toilet-based device.